posaconazole · Msd Merck Co · NDA 214770
Noxafil Powdermix Kit
Earliest generic entry, as listed
27 Jan 2029
Blocked by exclusivity: I-984.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 1 unexpired
| I-984 | new indication (3 years) | 27 Jan 2029 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 214770 · 001 · RLD | for suspension, delayed release, oral | 300MG | 27 Jan 2029 |